Ashwagandha Without the Numbness: Dose, Timing & When to Stop (2026)

Why some people feel numb on ashwagandha

Ashwagandha's primary mechanism involves modulating the hypothalamic-pituitary-adrenal (HPA) axis, which governs the body's cortisol response to stress. In a 2012 randomized controlled trial, 300 mg of ashwagandha root extract twice daily for 60 days reduced serum cortisol by 27.9% compared to placebo in adults with chronic stress (Chandrasekhar et al., 2012). A 2019 trial found similar cortisol reduction alongside significant improvements in sleep quality and reduced anxiety scores (Salve et al., 2019).

Cortisol is not only a "stress hormone." At normal levels, it drives motivation, alertness, and emotional responsiveness. When ashwagandha reduces cortisol below the threshold an individual needs for emotional engagement, the result is not relaxation but emotional blunting: a state where stress decreases but so does the capacity to feel pleasure, urgency, or connection. Users describe this as "not caring about anything," "feeling like a robot," or "two days of just not caring."

This response is not universal. Most users in clinical trials report reduced anxiety without emotional flattening. But the users who do experience it describe it as deeply uncomfortable, sometimes more disturbing than the anxiety they were trying to treat. The difference appears to come down to individual baseline cortisol levels, dose sensitivity, and how the individual's GABAergic system responds to withanolides (ashwagandha's active compounds). People with already-low baseline cortisol are more likely to overshoot into blunting territory.

How users describe the numbness (and what the words signal)

Clinical trials measure cortisol levels, anxiety scores, and sleep quality. What they do not capture is the lived experience of emotional blunting, which users describe in language that is more vivid and more actionable than any rating scale. Understanding this language helps you recognize the signs in yourself before they become distressing.

On the positive end, users who find the right dose describe ashwagandha in terms of subtraction: "fewer racing thoughts," "a general sense of calm," "I do feel more relaxed, especially in the evenings," "take the edge off." These descriptions share a pattern, something unpleasant has been reduced, and the user still feels like themselves. This is the target state.

On the negative end, users who have overshot describe the experience in terms of absence: "two days of just not caring about anything," "feeling numb," "emotionally flat," "I felt an emotional disturbance, a feeling that I couldn't control myself." The critical distinction: absence of anxiety is what you want, absence of caring is what you do not. When users start describing their experience using words like "numb," "flat," "indifferent," or "zombie," they have crossed from therapeutic benefit into overcorrection. This is the dose-too-high signal that should trigger a reduction or discontinuation.

A separate category of reports describes paradoxical reactions: anxiety worsening on ashwagandha. One WebMD reviewer described taking ashwagandha for two to three weeks with the goal of reducing anxiety, only to find that "during this period my anxiety got worse, my panic attacks and deep breathing intensified." This pattern is less common than numbness but is documented. It may reflect individual variation in how withanolides interact with the GABAergic system. If anxiety increases rather than decreases after two to three weeks of consistent use, ashwagandha is not the right compound for your neurochemistry, and no dose adjustment will fix it. Stop and explore the alternatives listed later in this article.

Can changing when you take it reduce the flatness?

If you are feeling flat or drowsy, when you take ashwagandha can matter as much as how much, because its cortisol-lowering effect interacts differently with your circadian rhythm at different times of day. (This section covers timing specifically as it relates to numbness and sedation; for a full morning-vs-night dosing guide across all goals, see our best time to take ashwagandha article.)

Morning dosing reduces cortisol during the hours when it is naturally highest. This can produce calm focus for users with stress-driven anxiety, but it can also cause daytime drowsiness, fatigue, or "brain fog" in users who need that cortisol peak for energy and alertness. Users who report feeling "tired," "hungover," or "slow" on ashwagandha are often taking it in the morning when their cortisol-to-alertness ratio is already optimal. In these cases, shifting the dose to evening may preserve the anxiety benefit while eliminating the daytime sedation.

Evening dosing aligns ashwagandha's cortisol-lowering effect with the body's natural cortisol decline before sleep. Two randomized controlled trials have demonstrated that evening ashwagandha significantly improves sleep onset latency and sleep quality (Langade et al., 2019; Salve et al., 2019). For users whose primary complaint is racing thoughts at night and difficulty falling asleep, evening dosing may be the better starting point.

Split dosing (half in the morning, half in the evening) is the protocol used in the Chandrasekhar 2012 trial that demonstrated 27.9% cortisol reduction. This approach provides steadier withanolide levels throughout the day but delivers a lower peak dose at each time point, which may reduce the risk of numbness compared to taking the full dose at once. If you are following the dose-escalation protocol above, split dosing is a natural next step after establishing that the half dose is tolerated.

The anxiety-medication question: can ashwagandha replace SSRIs?

This is the question that drives many people to ashwagandha in the first place. The typical narrative in user forums goes: "I don't want to take antidepressants because they make me numb and sleepy, so I'm looking for something natural." The irony is that the very side effect they are trying to avoid with SSRIs, emotional blunting, is the same side effect some users experience with ashwagandha at excessive doses.

Ashwagandha is not a replacement for prescribed psychiatric medication. The two operate through fundamentally different mechanisms, and the conditions they address have different levels of severity. Ashwagandha has demonstrated efficacy for perceived stress and subclinical anxiety in otherwise healthy adults. It has not been studied as a treatment for generalized anxiety disorder (GAD), panic disorder, social anxiety disorder, PTSD, or major depressive disorder in the way that SSRIs and other psychiatric medications have been.

If you are currently taking an SSRI, SNRI, or benzodiazepine, do not discontinue it in favor of ashwagandha without discussing the change with your prescribing physician. Abrupt discontinuation of SSRIs can cause serotonin discontinuation syndrome, which is a genuine and sometimes serious medical event. Ashwagandha may be used alongside prescribed medication in some cases, but this should be done under medical supervision because of potential interactions with sedatives and thyroid medications.

For users with mild-to-moderate stress-related anxiety who are not on prescription medication, ashwagandha is a reasonable and evidence-supported option to try: with the dosing, cycling, and monitoring protocols described above. For users with diagnosed anxiety disorders or depression, professional medical care comes first, and ashwagandha is at most a complementary tool, not a primary treatment.

The dose-escalation protocol: start low, observe, adjust

The majority of numbness reports in user forums and review sites describe users who started at the full manufacturer-recommended dose, often 600 mg of KSM-66 or equivalent, on day one. This is the fastest way to trigger the very side effect they fear most. A more cautious approach:

Week 1–2: half dose (150–300 mg KSM-66)

Start at half the labeled dose. For a product containing 600 mg KSM-66 per capsule, this means opening the capsule and taking half, or choosing a product with a lower per-capsule dose. Track three things daily: anxiety level (1–10 scale), emotional engagement (do you care about the things you normally care about?), and sleep quality. If anxiety decreases and emotional engagement remains stable, the dose is working as intended.

Week 3–4: evaluate before increasing

If the half dose provides sufficient anxiety relief, stay there. There is no clinical reason to increase a dose that is already producing the desired effect. The trials that demonstrated cortisol reduction and anxiety improvement used doses ranging from 300 mg to 600 mg of root extract daily, the lower end of this range is effective for many people. A 2019 trial specifically found that 250 mg of ashwagandha root extract twice daily was sufficient to produce significant improvements in sleep quality and stress resistance (Langade et al., 2019).

If the half dose produces no noticeable effect after three to four weeks, increase to the full dose (300 mg twice daily or 600 mg once daily). Continue monitoring emotional engagement alongside anxiety. If numbness appears at the full dose, drop back to the half dose, that is your ceiling.

Numbness watch: a week-by-week timeline

Based on the trial timelines from Chandrasekhar (60 days) and Salve (8 weeks), and corroborated by consistent patterns in user reports, here is a realistic timeline for ashwagandha at 300–600 mg/day of KSM-66:

If you feel nothing after four to six weeks at the full dose, ashwagandha is unlikely to work for you at any dose. This is not a failure, it reflects individual variation in how your HPA axis and GABAergic system respond to withanolides. Move to the alternatives section rather than increasing the dose further.

The stop signals: when to discontinue

Stop taking ashwagandha and consult your healthcare provider if you experience any of the following: emotional flatness or indifference lasting more than two consecutive days, feeling "zombie-like" or disconnected from people you care about, worsening anxiety or panic attacks (paradoxical response reported by some users), unusual fatigue or excessive sleepiness during the day, gastrointestinal distress that does not resolve after the first week, or any sign of liver discomfort (dark urine, upper right abdominal pain, yellowing of eyes or skin).

The liver signal deserves special emphasis. A 2025 case series review documented multiple instances of ashwagandha-associated hepatotoxicity, confirming it as a rare but real risk (Casiano-Manzano et al., 2025). A 2023 systematic assessment using the Roussel Uclaf Causality Assessment Method (RUCAM) rated the causal relationship between ashwagandha and liver injury as "probable" in several documented cases (Bokan et al., 2023). These cases are rare relative to the millions of users, but they establish that liver monitoring is prudent for anyone using ashwagandha beyond eight weeks.

How long before you should take a break?

Most clinical trials run 8 to 12 weeks, and the NIH Office of Dietary Supplements states ashwagandha appears safe for up to 3 months. Beyond that window, systematic safety data thins out. The practical relevance to numbness: the longer you take ashwagandha continuously, the more your HPA axis adapts, and some users report that emotional flatness creeps in around week 6 to 8 even at a dose that felt fine initially. If you notice this, it is a signal to take a break rather than push through. We cover cycling schedules and the reasoning behind them in detail in our ashwagandha withdrawal and cycling guide. The short version: an 8-to-12-week-on, 2-to-4-week-off rhythm gives the HPA axis a reset and gives you a window to reassess whether the numbness was dose-related or duration-related.

Does the extract type affect the numbness risk?

It can. Sensoril is a root-and-leaf extract standardized to a higher withanolide concentration (10%) than KSM-66 (5%), and it is typically dosed lower as a result. Because the numbness effect tracks with withanolide load, a person sensitive to blunting may find a lower-withanolide root-only extract like KSM-66 easier to titrate. But this is secondary to getting the dose right, the same extract will blunt or not blunt depending primarily on how much you take. For a full comparison of the extract types, their withanolide content, and the clinical evidence behind each, see our KSM-66 vs regular ashwagandha and what is KSM-66 guides.

Who should not take ashwagandha

Ashwagandha interacts with several medication classes and is contraindicated in certain conditions. Based on the NIH ODS fact sheet and published case reports, avoid ashwagandha if you are taking thyroid medications (ashwagandha may increase thyroid hormone levels, potentially requiring dose adjustment), sedatives or benzodiazepines (additive CNS depressant effects), immunosuppressants (ashwagandha may stimulate immune function, counteracting the drug), or blood sugar-lowering medications (additive hypoglycemic effects).

Ashwagandha should also be avoided during pregnancy (insufficient safety data and traditional Ayurvedic texts classify it as potentially abortifacient), breastfeeding, and in individuals with autoimmune thyroid disease (Hashimoto's or Graves') without physician guidance. A 2026 systematic ethnobotanical review specifically flagged the thyroid interaction as clinically significant, noting that ashwagandha can alter TSH, T3, and T4 levels in ways that may be beneficial for hypothyroidism but dangerous for hyperthyroidism (Tallon et al., 2026).

For a complete list of drug interactions, see our ashwagandha drug interactions guide.

Alternatives if ashwagandha does not work for you

If you have tried ashwagandha and experienced numbness, paradoxical anxiety, or simply no effect, you are not out of options. Several other evidence-based compounds address anxiety through different mechanisms:

L-theanine (200 mg) is the most common recommendation for people who find ashwagandha too strong. It promotes calm by increasing alpha brain wave activity, the same pattern seen during meditation: without sedation, cortisol suppression, or HPA axis modulation. It works within 30 to 60 minutes of a single dose and does not accumulate with repeated use, so there is no cycling concern, no withdrawal risk, and no emotional blunting. Users describe it as "taking the edge off without taking anything away." It can be combined with caffeine for focused, alert calm, a combination that has been studied in several small trials and is the basis of many nootropic stacks. For people who experienced numbness on ashwagandha, L-theanine often provides the narrower effect they were originally looking for: reduced mental noise without any alteration to emotional range. For more details, see our ashwagandha and L-theanine comparison.

Magnesium glycinate supports GABA receptor function and is one of the most commonly deficient minerals in people with chronic stress, studies estimate that 50% or more of Western populations do not meet the recommended daily intake. Unlike ashwagandha, which modulates the HPA axis systemically, magnesium addresses a specific, measurable nutritional gap. If your magnesium is low (which your doctor can check with an RBC magnesium test, not the standard serum test), correcting the deficiency can produce anxiety reduction, better sleep, and reduced muscle tension without any of the cortisol-suppression mechanisms that cause emotional blunting. Many users who find ashwagandha too strong report that magnesium glycinate at 200 to 400 mg in the evening provides a gentler and more predictable calming effect. See our ashwagandha and magnesium guide.

Rhodiola rosea is an adaptogen with a fundamentally different stress-response profile than ashwagandha. Where ashwagandha calms by reducing cortisol, rhodiola supports stress resilience by modulating the stress-response system without suppressing it. In practice, this means rhodiola tends to be more energizing and less sedating: making it a significantly better fit for people whose anxiety is accompanied by fatigue, low motivation, or burnout rather than hyperarousal and restlessness. Users who find ashwagandha "too heavy" or "too sedating" often respond better to rhodiola's lighter, more stimulating profile. Typical doses are 200 to 400 mg of a standardized extract (3% rosavins, 1% salidroside) taken in the morning. For a head-to-head comparison of mechanisms, trial data, and which anxiety profile each serves best, see our ashwagandha vs rhodiola analysis.

What ashwagandha can and cannot do: setting expectations

Ashwagandha can reduce perceived stress and cortisol levels, based on multiple randomized controlled trials. It can improve sleep onset and sleep quality. It can support body composition in conjunction with resistance training. It can reduce anxiety scores in otherwise healthy adults experiencing chronic stress.

Ashwagandha cannot cure anxiety disorders. It cannot replace therapy or behavioral interventions. It cannot guarantee that you will respond positively, because individual neurochemistry varies. And it cannot be used indefinitely without periodic reassessment, because long-term safety data beyond 12 weeks is limited. Setting these expectations before you start is the difference between a measured, productive experience and a cycle of hope and disappointment. If ashwagandha does what the evidence suggests it can do: reduce cortisol, ease stress, improve sleep, that is a meaningful benefit. If you expect it to eliminate anxiety entirely, you will be frustrated regardless of the product quality.

Why YourHealthier Ashwagandha Plus

Our Ashwagandha Plus 600mg uses KSM-66, the most-studied ashwagandha extract, standardized to a minimum 5% withanolides. Each batch is third-party tested for withanolide content, heavy metals, and microbial contamination, with results available on our Lab Results page. The 600 mg single-capsule format allows easy dose adjustment: users following the low-start protocol described above can open the capsule and take half for the first two weeks.

Frequently Asked Questions

Does ashwagandha cause emotional numbness?

In a subset of users, yes. Emotional blunting or indifference is a consistent theme in user reviews and health forums, typically reported at doses above 600 mg/day of root extract or after use exceeding six to eight weeks without a break. Clinical trials have not specifically measured emotional flattening as an outcome variable: they measure anxiety scores, cortisol levels, and sleep quality, none of which capture the nuance of "not caring about anything." So the incidence rate is genuinely unknown. The mechanism is most likely related to excessive cortisol suppression below the threshold needed for normal emotional engagement and motivation. Cortisol is not only a stress hormone; it drives urgency, caring, and responsiveness to social and professional stakes. When it drops too far, stress decreases but so does the emotional energy that makes life feel meaningful. Reducing the dose to the minimum effective amount, or stopping entirely, resolves the numbness within a few days in most reports, because ashwagandha does not have a long half-life or accumulation pattern.

Will the numbness go away if I lower my dose instead of stopping?

Usually, yes. Because emotional blunting on ashwagandha is dose-dependent, driven by cortisol suppression dropping below the level you need for normal emotional engagement, reducing to the minimum effective dose often resolves the flatness while preserving the anxiety benefit. Try halving your dose and tracking emotional engagement for a week before deciding whether to stop entirely. If the numbness persists even at a low dose, ashwagandha may not suit your neurochemistry, and the alternatives section above is the better path. (If you do decide to stop after high-dose use, taper gradually, see our ashwagandha withdrawal guide.)

How long should you take ashwagandha?

The NIH states ashwagandha appears safe for up to 3 months. Most clinical trials are 8 to 12 weeks. A common cycling protocol is 8 to 12 weeks on, followed by 2 to 4 weeks off. Some users prefer a shorter rhythm of 6 weeks on, 2 weeks off, which provides more frequent reset points and may be better for people who are sensitive to cortisol suppression. The off-period serves a dual purpose: it gives the HPA axis a physiological reset, reducing the risk of cortisol suppression becoming excessively deep, and it provides valuable self-assessment data. During the off-period, pay close attention to how you feel without the supplement: your sleep quality, stress reactivity, and emotional range. This information tells you whether ashwagandha is providing genuine, ongoing benefit or whether the initial effect has plateaued. If you choose to continue beyond 12 weeks without cycling, periodic liver function blood tests are a reasonable precaution given the documented, though rare, hepatotoxicity risk.

Is ashwagandha safe for your liver?

Multiple case reports have documented ashwagandha-associated liver injury, and a 2023 RUCAM assessment rated the causal relationship as "probable" in several cases (Bokan et al., 2023). The absolute risk is low relative to the large number of users worldwide, but it is not zero. Symptoms to watch for include dark urine, upper right abdominal pain, unusual fatigue, and yellowing of eyes or skin. If any appear, stop ashwagandha and get liver function tests immediately. For more details, see our ashwagandha liver safety guide.

What is the best time to take ashwagandha?

It depends on your primary goal and your sensitivity to sedation. For anxiety reduction throughout the day without drowsiness, morning dosing with breakfast works best for most users. For sleep improvement, particularly difficulty falling asleep due to racing thoughts, evening dosing 30 to 60 minutes before bed aligns ashwagandha's cortisol-lowering effect with your body's natural sleep preparation. If you are taking 600 mg daily as a split dose (the protocol used in the Chandrasekhar 2012 trial that demonstrated 27.9% cortisol reduction), take 300 mg with breakfast and 300 mg with dinner. Split dosing provides steadier withanolide levels throughout the day and delivers a lower peak dose at each time point, which may reduce the risk of emotional blunting compared to a single large dose. Taking with food consistently reduces the gastrointestinal side effects that some users report in the first week. For a full timing guide with additional trial data, see our when to take ashwagandha article.

Can ashwagandha replace anti-anxiety medication?

No. Ashwagandha is a dietary supplement, not a medication. It has not been evaluated or approved by the FDA for the treatment or management of any anxiety disorder, and the clinical trials demonstrating its anxiolytic effects were conducted in otherwise healthy adults experiencing stress: not in patients with diagnosed generalized anxiety disorder, panic disorder, social anxiety disorder, or PTSD. The populations and the conditions are meaningfully different, and extrapolating from one to the other is not supported by the current evidence base.

If you are currently taking a prescribed anti-anxiety medication: whether an SSRI, SNRI, benzodiazepine, or buspirone, do not discontinue it in favor of ashwagandha without consulting your prescribing physician. Abrupt discontinuation of SSRIs can cause serotonin discontinuation syndrome, and abrupt benzodiazepine cessation can cause seizures. These are medical events, not side effects of natural supplements, and they require medical management. Some users find ashwagandha helpful as a complement to prescribed treatment and therapy, but it occupies a supporting role in that context, not a primary one.

Our Batch-Level Purity Testing

Every YourHealthier product undergoes independent third-party testing at ISO 17025-accredited laboratories. We publish certificates of analysis by batch number so you can verify the exact product you purchased. View current results on our Lab Results page.

Testing & Transparency Methodology

All dosing protocols, clinical trial data, and safety information in this article are sourced from peer-reviewed studies on PubMed and the NIH Office of Dietary Supplements fact sheet on ashwagandha. User experience data (emotional numbness, withdrawal concerns) is drawn from published user reviews on WebMD and health forums, cited as anecdotal context rather than clinical evidence. We do not cite retracted studies or predatory journals.

References